CATABASIS PHARMACEUTICALS IN - COM (CATB)

CUSIP: 14875P107

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM
Total 13F shares
285,765
Share change
-20,708,888
Total reported value
$1,249,000
Price per share
$4.37
Number of holders
1
Value change
-$25,751,063
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 14875P107?
CUSIP 14875P107 identifies CATB - CATABASIS PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CATABASIS PHARMACEUTICALS IN - COM (CATB) as of Q4 2018

As of 31 Dec 2018, CATABASIS PHARMACEUTICALS IN - COM (CATB) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 285,765 shares. The largest 1 holders included SV Health Investors, LLC. This page lists 1 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.